Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. - Wikidata - awgldk - TriplyDB

Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.

Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.

http://www.wikidata.org/entity/Q53171227

about

Focal liver lesions: Practical magnetic resonance imaging approach Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.New concept: cellular senescence in pathophysiology of cholangiocarcinoma.Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.Intrahepatic cholangiocarcinomas mimicking other lesions.Comparison of clinicopathological characteristics between cirrhotic and non-cirrhotic patients with intrahepatic cholangiocarcinoma: A large-scale retrospective study.Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics.Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis.Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging.

P2860

Q26799474-A395F5D5-A3EB-4A6B-B181-5D27855E2D4F Q28075361-5424D621-0398-4453-8899-D7BE4F8982D3 Q35721144-05BB86CC-0532-4390-8AF5-8ABBB96B9908 Q38245527-3CEEF64B-D740-4654-A921-DF77C894EE50 Q38587512-E4CF316A-5D5B-46C3-8931-097971D25106 Q38647654-679E08DC-7787-4D7B-A6A5-CB1172CB1910 Q38672946-83506B9E-60FF-403B-8811-1D4020B3AA28 Q38684422-B6FAA234-51DA-4E93-B6AF-CDD5FE9F125E Q40822421-24604E69-1842-4EC8-ACDD-910513089863 Q42376329-A7CD7CF2-AF89-4124-A010-2C352E9863C7 Q45845828-62835A84-02AC-48BF-889F-C3C0599AB38A Q47403153-3FA6DEB0-D57E-4E6A-9AD0-0426D718E5E3 Q47730953-07E8A8E6-DC09-41E2-8203-623895302DE7 Q48000860-8738811C-B1AD-49CA-AB44-410EB87B787E Q48283681-A4D63349-4D66-4F87-A810-421E1D6CB321 Q51147978-0F3F0816-AD67-4A74-B9D3-B2F4CEC2A923 Q52982866-9BC50118-82A2-4CF7-BE88-C5B062593826 Q53064436-685BAD01-8FB2-4A7D-8CC0-B2FA81D8A04D Q53495227-A04E7F57-E207-410E-AC69-6F08240E5E0D Q55260939-96DE4034-8BC4-4305-9B4B-C160D8D8CF51

P2860

Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.

http://www.wikidata.org/entity/Q53171227

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Intrahepatic cholangiocarcinom ...... n with those in normal livers.

@en

Intrahepatic cholangiocarcinom ...... n with those in normal livers.

@nl

type

label

Intrahepatic cholangiocarcinom ...... n with those in normal livers.

@en

Intrahepatic cholangiocarcinom ...... n with those in normal livers.

@nl

prefLabel

Intrahepatic cholangiocarcinom ...... n with those in normal livers.

@en

Intrahepatic cholangiocarcinom ...... n with those in normal livers.

@nl

P1433

Q53171227-C192A387-CE8A-4A52-857C-93139C6BEF42

P1476

Q53171227-A21E4224-2268-41CE-88E9-1FADF84C8602

P2093

Q53171227-2311079F-86D0-4974-A154-4C468788BF30

Q53171227-247DD326-BFAF-4A1F-B2AE-6ADD1FD19BEA

Q53171227-28F0DDEA-0A55-4CAE-B64F-859EA2A9B6EF

Q53171227-2F98ACCE-9423-4624-B106-AC1C85E2C84B

Q53171227-451035BD-1BEA-4B2B-B641-4EDD0BAEEC3E

Q53171227-540E8089-A0D3-4FA7-BFBE-7ED054C01605

Q53171227-8C97B496-8ADD-4472-AA65-9FD7CA20A3E2

Q53171227-A6383FD8-24FC-4D66-9BC4-CBC136320A7A

Q53171227-A9E2DE0C-6A0C-4088-8880-856ED0A90361

Q53171227-B477B5B8-0C17-48E5-8C27-3A711886616C

P2860

Q53171227-0FEF2969-6F58-438E-A319-94A8A72B8736

Q53171227-1D79660C-7131-4F54-B3C3-249281B48D8C

Q53171227-1F9E7425-3835-43AB-AAEF-2C464B392ECB

Q53171227-3BD6ACC9-7443-43D8-8CB4-0ECA0A74CECD

Q53171227-4CCDB1FB-E5F3-47CF-967C-8F9CE17B6058

Q53171227-630D836D-246F-47C1-945C-070FA3378854

Q53171227-831FBAA0-14C9-48A9-B0C0-359E192197DC

Q53171227-88DEEF02-1BBC-4C57-A408-115731ECE708

Q53171227-9FD54C84-DA34-46AD-9848-01362271EEC6

Q53171227-B54B2E11-76FB-41C4-A172-451434AF2C00

P304

Q53171227-BEB3D69D-0A42-4B2F-BBB7-216930C7D6D3

P31

Q53171227-525803B9-436A-4DBF-BCF8-70DE2F54916C

P356

Q53171227-BAF23FF3-92D5-4B88-B79D-7FBB36877441

P433

Q53171227-EB9B029B-38F7-431F-AA47-83221A5C2D34

P478

Q53171227-E5B161C0-A2B5-4956-AF07-CA3BB4FF141A

P577

Q53171227-DD4BEF43-40D7-43A0-95B0-C27FAF1AF1ED

P698

Q53171227-BD3F08CF-A130-4926-B5E5-1CB09DDE988A

P921

Q53171227-A64B2CA6-F4A9-4145-A915-050AA9E761A4

Q53171227-C3762457-8592-4EB8-B0BB-94567E0515DF

P356

J.1478-3231.2012.02783.X

P1433

Liver International

P1476

Intrahepatic cholangiocarcinom ...... n with those in normal livers.

@en

P2093

Eunsil Yu

http://www.w3.org/2001/XMLSchema#string

Hiroko Ikeda

http://www.w3.org/2001/XMLSchema#string

Jihun Kim

http://www.w3.org/2001/XMLSchema#string

Jing Xu

http://www.w3.org/2001/XMLSchema#string

Kazuto Kozaka

http://www.w3.org/2001/XMLSchema#string

Motoko Sasaki

http://www.w3.org/2001/XMLSchema#string

Norihide Yoneda

http://www.w3.org/2001/XMLSchema#string

Osamu Matsui

http://www.w3.org/2001/XMLSchema#string

Saya Igarashi

http://www.w3.org/2001/XMLSchema#string

Takashi Matsubara

http://www.w3.org/2001/XMLSchema#string

P2860

Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology.

Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment.

Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.

Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.

Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.

Characterization of liver lesions by real-time contrast-enhanced ultrasonography.

Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.

Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis.

P304

1156-1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2012.02783.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22417172

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

liver cirrhosis